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A B S T R A C T
 
The incidence of sexually transmitted diseases among adolescents is increasing worldwide. 
Genital Chlamydia trachomatis infection is one of the most prevalent sexually transmitted 
diseases in young women, and undetected disease is highly associated with long-term 
complications in women. Our goal was to determine the prevalence of cervical Chlamydia 
trachomatis infection in a sexually active population of female adolescents from Salvador, 
Brazil, and to describe their socio-demographic, behavioral, and clinical characteristics. 
100 sexually active adolescents (10-19 years) were included in this study, between 2008 
and 2010. Endocervical samples were obtained during gynecological examination. In-
house polymerase chain reaction of cervical specimens was used for Chlamydia trachomatis 
detection. The overall prevalence of cervical Chlamydia trachomatis infection was 31% 
(95% CI 22-40). There were no statistically significant differences in the age at first sexual 
intercourse, number of sexual partners, and frequency of condom use between Chlamydia 
infected and uninfected adolescents. The prevalence of cervical Chlamydia trachomatis 
infection among adolescents from Salvador was the highest in Brazil up to the present date. 
These results demonstrate an urgent need for continued and comprehensive prevention 
strategies along with proper screening for Chlamydia in high-risk populations in order to 
decrease the rates of infection. 
Adolescence is defined as the period between the ages of 
10 and 19 years. According to The State of the Worlds Children 
2011,1 around 11% of the Brazilian population is composed of 
adolescents. In Latin America, about 22% of adolescent females 
claimed to have had their sexual initiation before age 15.1,2 
This scenario presents sexually transmitted diseases (STDs) 
in this period of life as an increasingly urgent public health 
concern.3
Chlamydia trachomatis (CT) is one of the most prevalent 
pathogens related to sexually transmitted diseases both 
overall and among young females.4,5 Chlamydial genital 
infections typically present with mild and non-specific 
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signs and symptoms,6 although the majority of them are 
asymptomatic.5,7 In women, undetected infections are highly 
associated with harmful and costly complications, such as 
pelvic inflammatory disease (PID), infertility, and ectopic 
pregnancy.4-8 At the present time, few studies have been 
conducted in order to estimate the prevalence of CT among 
Brazilian adolescent females.5
The aim of this study was to assess the prevalence of 
cervical CT infection in a population of female adolescents 
from the city of Salvador, northeastern Brazil, and to 
describe their socio-demographic, behavioral and clinical 
characteristics. A group of 100 adolescent females from 
the Adolescent Gynecology Clinic (Serviço de Ginecologia 
para Adolescentes – SEGIA) of the Escola Bahiana de 
Medicina e Saúde Pública (EBMSP – Salvador, Bahia, Brazil) 
were included in this study, between September 2008 and 
September 2010. This is a free outpatient unit that has 
provided comprehensive care to a total of 300 patients since 
2008. Patients were sequentially enrolled at the moment of 
their medical appointment. Inclusion criteria were female 
gender, age between 10 and 19 years and sexual activity. 
Exclusion criteria were pregnancy or postpartum status, use 
of vaginally applied medication over three days prior to the 
gynecological examination. This study was approved by 
the Institutional Review Board of EBMSP. An informed consent 
form was signed by all the legally responsible persons for the 
adolescents prior to their participation in the study. Patients 
aged 18 years or older signed it themselves. 
Demographic and clinical data were obtained by specific 
standardized data collection forms. Endocervical samples 
were collected with appropriate swabs, during gynecological 
examination. The DNA was extracted from cervical specimens 
using the Qiamp® DNA Mini Kit (Qiagen, Hilden – Germany). 
Then, in-house polymerase chain reaction (PCR) was 
carried out for genetic amplification, using the following 
primers: KL1-5TCCGGAGCGAGTTACGAAGA3 and KL2-
5’AATCAATGCCCGGGATTGGT3. A fragment of 241 base pairs 
was amplified. 
Standard descriptive analysis of all variables was per-
formed, including: frequency distributions for ethnic groups; 
family income; conjugal status; education; alcohol, tobacco 
and illegal drug use; history of family violence; age at first 
sexual intercourse; sexual abuse; contraceptive use; con-
dom use; and number of sexual partners. Mean and stand-
ard deviation were calculated for age and age at menarche. 
Prevalence with a corresponding confidence interval (95% CI) 
was also calculated. Qui-square and Fisher’s exact tests 
were used to study associations between CT-positivity 
and socio-demographic, behavioral and clinical variables. 
A p-value of ≤ 0.05 was considered statistically significant. 
All data were analyzed using the Statistical Package for 
Social Sciences (SPSS)  version 17.0 PC software (IBM SPSS – 
Chicago, IL, USA).
Socio-demographic and behavioral characteristics of 
the study population are outlined in Table 1. The mean age 
of participants was 16.6 ± 1.6 years, 91% were non-white, 
and 80% were married or living with a partner. About 44% had 
more than 9 years of education, and 49% belonged to families 
whose earnings were equal to one minimum wage or less. The 
overall prevalence of cervical Chlamydia trachomatis infection 
was 31% (95% CI: 22-40). There were no significant differences 
in the age at first sexual intercourse and condom use between 
CT-infected and uninfected adolescents. About 10% of 
the CT-infected women have had five or more sexual partners 
in their lifetime, while 5.8% of uninfected patients reported 
the same. However, this difference was not statistically 
significant.
Current genitourinary characteristics of CT-infected and 
uninfected patients are specified in Table 2. Vaginal discharge 
was reported by more than half of CT-infected patients. The 
frequencies of genital itching (16.6%) and abdominopelvic 
pain (6.6%) were also greater for CT-positive individuals. 
There was a similar frequency of dysmenorrhea in the two 
groups, while dysuria was reported only among CT-uninfected 
individuals. Genital lesions and vaginal hyperemia were 
more often observed in CT-negative patients (10.1%). 
However, none of the previously described differences 
achieved statistical significance. 
This study demonstrated a high prevalence of CT (31%) 
among sexually active adolescent females from Salvador, a 
city located in northeastern Brazil. The vast majority of these 
adolescents belonged to socioeconomically disadvantaged 
groups, were relatively less educated, and had very low 
family incomes, usually equal to one minimum wage or less. 
Additionally, more than one third of them had their sexual 
initiation before 14 years of age, and 80% were married or living 
with a partner. 
Previous studies conducted in Brazil showed lower 
prevalences of genital Chlamydia infection, ranging from 12.2% 
to 22.2%.5,7 The epidemiological profile of the adolescents 
did not seem to be important in determining these 
differences in the prevalence of CT infection. There were 
similarities between this study and the previous ones 
in relation to the level of education, age of sexual initiation, 
and number of sexual partners of participants.5,7 However, 
there was heterogeneity regarding the diagnostic methods 
used and the age group evaluated. The highest prevalences 
were observed when endocervical samples were analyzed by 
molecular techniques.5,9 The studies in which urine specimens 
were used showed CT prevalence ranging from 12.2% to 16%.7,10 
Despite the fact that both techniques are comparable in terms 
of specificity and sensitivity,11 it has been demonstrated that 
the use of cervical samples is more accurate for CT detection in 
general.12,13 Relatively high rates of CT infection in adolescent 
females were also observed in some worldwide studies,3,8,14 
ranging from 9.6% to 17.4%. Most of these studies screened 
low-income urban populations reporting high-risk behavior 
for STDs.8,14
The most common presenting symptoms among 
CT-infected adolescents were vaginal discharge and genital 
itching. Abdominopelvic pain was reported by less than 10% 
of adolescents. This clinical presentation is similar to those 
described in previous studies.3,4 Genital chlamydial infections 
usually display a nonspecific pattern of signs and symptoms, 
and are highly associated with important complications when 
misdiagnosed or mistreated.4-8 This is in spite of its well 
documented spontaneous resolution, whose rates ranges from 
11% to 57%.15
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                 n = 100 CT positive patient 
(n = 31)
CT negative patients 
(n = 69)
p-value 
Age (years) 16.6 ± 1.6 16.8 ± 1.6 16.5 ± 1.6 0.44
Ethnic group 0.45
 Non-white 91 27 (87) 64 (92.7)
 White 9 4 (12.9) 5 (7.2)
Conjugal status 0.66
 Married/living together 80 24 (77.4) 56 (81.1)
 Single 20 7 (22.5) 13 (18.8)
Family income (minimum wages†)* 0.92
 1 49 16 (51.6) 33 (48.5)
 2 to 4 47 14 (45.1) 33 (48.5)
 ≥ 5 3 1 (3.2) 2 (2.9)
Education* 0.46
 < 9 years (primary/intermediate) 44 15 (50) 29 (42)
 ≥ 9 years (secondary/higher) 55 15 (50) 40 (58)
 Alcohol, tobacco and illegal drug use 52 13 (41.9) 39 (56.5) 0.17
 History of family violence* 22 10 (33.3) 12 (17.4) 0.08
 Age at menarche (years)‡ 12.3 ± 1.6 12.6 ± 1.7 12.2 ± 1.5 0.41
Age at first sexual intercourse (years) 0.48
 ≤ 14 34 9 (29) 25 (36.2)
 ≥ 15 66 22 (71) 44 (63.7)
Sexual abuse 3 2 (6.4) 1 (1.4) 0.22
Contraceptive use 41 12 (38.7) 29 (42) 0.75
Condom use 0.85
Never/sometimes 53 16 (51.6) 37 (53.6)
Always/almost always 47 15 (48.3) 32 (46.3)
Number of sexual partners* 0.43
 1 to 4 92 27 (90) 65 (94.2)
 ≥ 5 7 3 (10) 4 (5.8)
Data are presented as mean ± SD (standard deviation) for continuous variables and n (%) for categorical variables. STD, sexually transmitted 
diseases; †approximately 330 US dollars; *data was available for 99 subjects; ‡the specific age at menarche was available for 59 subjects, 
considering it was ≤ for all participants.
Table 1 - Socio-demographic and behavioral characteristics of the study population (n = 100)
 CT positive (n = 30) CT negative (n = 69) p-value
Vaginal discharge 16 (53.3) 32 (46.3) 0.58
Genital itching 5 (16.6) 4 (5.8) 0.12
Dysmenorrhea 3 (10) 7 (10.1) 1.00
Abdominal/pelvic pain 2 (6.6) 4 (5.8) 1.00
Dysuria 0 1 (1.4) 1.00
Genital lesions and/or vaginal hyperemia 2 (6.6) 7 (10.1) 0.71
Data are presented as n (%). 
Table 2 - Genitourinary signs, symptoms and diseases of the study population stratified by Chlamydia trachomatis (CT) 
infection status (n = 99)
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The small sample size of this study might limit inference of 
results to other similarly aged women in Brazil.4,7 However, it 
was the first study carried out exclusively among adolescents 
in the northeast region of the country. As both CT-infected and 
uninfected groups exhibited comparable socio-demographic 
and behavioral characteristics, and the majority of participants 
were in stable relationships, it could be inferred that the 
epidemiological profile of their partners was partially or 
mainly responsible for the overall high rates of Chlamydia. 
Nevertheless, the partners of subjects were not investigated 
in this study, which could be identified as another limitation. 
Further studies should be conducted in order to estimate the 
countrywide prevalence of genital CT in both male and female 
adolescents.
The prevalence of cervical CT infection among adolescents 
from Salvador demonstrated in this study was the highest in 
Brazil to date. These results underscore the need to enhance 
current STD-preventive public health policies focused on this 
age group, and to provide free screening tests for Chlamydia 
in public outpatient settings. This could have an impact on 
women’s future reproductive health and contribute to the 
prevention of other STDs.
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